Delivery Order SPE2DB20D1100-SPE2DB25FE2G1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (UU 30s) with a contract value of $8,928.96 under a firm fixed-price arrangement. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. This delivery order represents a non-set-aside, competitively awarded transaction that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a $2,879.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) under contract 4569461903. The award, announced on September 15, 2025, with completion targeted for September 16, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999.999 billion through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,373.85 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction supporting federal medical procurement needs. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $1,545.46 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a non-set-aside competitive award, with performance to occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,405.94 to AmerisourceBergen Drug Corp for 30 tablets of Vemlidy 25 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance to be completed at the contractor's Conshohocken, Pennsylvania facility. The contract is a child award under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,617.18 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Vemlidy is a prescription antiviral medication used in hepatitis B treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $2,873.72 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit package) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,828.40. This non-set-aside, competitively awarded delivery order has an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2G1Delivery Order
The Defense Logistics Agency awarded a $4,358.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets in a quantity of 30 units. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a non-set-aside competitive award, and performance will be executed from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Vemlidy, an antiviral medication used in the treatment of chronic hepatitis B, reflects the vendor's role in delivering specialized pharmaceutical products across multiple therapeutic domains to support federal medical supply requirements. The firm fixed-price delivery order structure demonstrates AmerisourceBergen's capability to fulfill federal medical procurement requirements through competitive acquisition processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/22/25 |